Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Inghammar, G. Engström, B. Ljungberg, C.G. Löfdahl, A. Egesten (Lund, Sweden). Chronic pulmonary diseases and the epidemiology of invasive pneumococcal infection. Eur Respir J 2012; 40: Suppl. 56, 1728

Member's Comments

No comment yet.

Related content which might interest you: Fungal VAP Source: Eur Respir Mon 2011; 53: 122-137 Year: 2011 Chronic obstructive pulmonary disease and nosocomial infections Source: Eur Respir J 2005; 26: Suppl. 49, 285s Year: 2005 Nontuberculous mycobacterial infection in chronic obstructive pulmonary disease Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Infection as a comorbidity of COPD Source: Eur Respir J 2010; 35: 1209-1215 Year: 2010 Analysis of efficiency of joint or consistent vaccination with pneumococcal and influenzal vaccines in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies Year: 2019 Impact of bacterial infections on airway diseases Source: Eur Respir Rev 2005; 14: 62-68 Year: 2005 Results of vaccination against pneumococcal infection in patients with chronic lung diseases Source: International Congress 2019 – Airway infection in COPD Year: 2019 Influenza and pneumococcal vaccines prevalence and their influance on asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 Effectiveness of polysaccharide pneumococcal vaccination among subjects with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 442s Year: 2006 Inhalative vaccination with pneumococcal polysaccharide in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 372s Year: 2007 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary diseases Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections Year: 2014 Impact of underlying respiratory diseases on clinical features and prognosis of chronic pulmonary aspergillosis Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015 Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: 782-800 Year: 2007 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Eur Respir Rev 2008; 17: 43-45 Year: 2008 Effects of pneumococcal vaccine in patients with chronic respiratory disease Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease Source: Annual Congress 2013 –Viral infections Year: 2013 Chronic pulmonary aspergillosis: prevalence, favouring pulmonary diseases and prognosis Source: Eur Respir J, 58 (2) 2003345; 10.1183/13993003.03345-2020 Year: 2021 Impact of pulmonary tuberculosis infection on chronic obstructive pulmonary disease Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 The pathophysiology of pneumococcal pneumonia Source: Eur Respir Monogr 2014; 63: 42-63 Year: 2014